NYSE:VSI - The Vitamin Shoppe Stock Price, Price Target & More

Get Started

$5.25 +0.10 (+1.94 %)

(As of 05/25/2018 04:00 PM ET)

Previous Close$5.25

Today's Range$5.05 - $5.25

52-Week Range$2.95 - $12.05

Volume347,821 shs

Average Volume579,308 shs

Market Capitalization$122.37 million

P/E Ratio13.46

Dividend YieldN/A

Beta0.48

About The Vitamin Shoppe (NYSE:VSI)

Vitamin Shoppe, Inc., through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products. It offers vitamins, minerals, herbs, specialty supplements, sports nutrition products, and other health and wellness products of approximately 900 brands, such as own brands comprising The Vitamin Shoppe, BodyTech, True Athlete, Mytrition, plnt, ProBioCare, Next Step, and Betancourt Nutrition; and national brands, including Optimum Nutrition, Cellucor, Garden of Life, Quest Nutrition, Solaray, Solgar, Megafood, and Nature's Way. The company sells its products through Vitamin Shoppe and Super Supplements retail stores, as well as through its vitaminshoppe.com Website. As of December 30, 2017, it operated through 785 Vitamin Shoppe and Super Supplements retail stores in 45 states, the District of Columbia, and Puerto Rico; and 8 franchise stores in Panama, 5 in Guatemala, 3 in Paraguay, and 2 in Costa Rica. The company was formerly known as VS Holdings, Inc. and changed its name to Vitamin Shoppe, Inc. in November 2009. Vitamin Shoppe, Inc. was founded in 1977 and is headquartered in Secaucus, New Jersey.

Receive VSI News and Ratings via Email

Sign-up to receive the latest news and ratings for VSI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Food stores

Sub-IndustrySpecialty Stores

SectorRetail/Wholesale

SymbolNYSE:VSI

CUSIP92849E10

Webwww.vitaminshoppe.com

Phone201-868-5959

Debt

Debt-to-Equity Ratio0.47

Current Ratio1.88

Quick Ratio0.44

Price-To-Earnings

Trailing P/E Ratio13.46

Forward P/E Ratio-27.63

P/E GrowthN/A

Sales & Book Value

Annual Sales$1.18 billion

Price / Sales0.11

Cash Flow$14.1892 per share

Price / Cash0.37

Book Value$7.69 per share

Price / Book0.68

Profitability

EPS (Most Recent Fiscal Year)$0.39

Net Income$-252,150,000.00

Net Margins-22.80%

Return on Equity1.28%

Return on Assets0.56%

Miscellaneous

Employees5,573

Outstanding Shares24,230,000

The Vitamin Shoppe (NYSE:VSI) Frequently Asked Questions

What is The Vitamin Shoppe's stock symbol?

The Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."

How were The Vitamin Shoppe's earnings last quarter?

The Vitamin Shoppe (NYSE:VSI) announced its quarterly earnings results on Wednesday, May, 9th. The specialty retailer reported $0.10 earnings per share for the quarter, meeting analysts' consensus estimates of $0.10. The specialty retailer earned $295.96 million during the quarter, compared to analysts' expectations of $293.44 million. The Vitamin Shoppe had a positive return on equity of 1.28% and a negative net margin of 22.80%. View The Vitamin Shoppe's Earnings History.

When is The Vitamin Shoppe's next earnings date?

The Vitamin Shoppe is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for The Vitamin Shoppe.

What price target have analysts set for VSI?

5 brokerages have issued twelve-month target prices for The Vitamin Shoppe's stock. Their forecasts range from $3.00 to $7.00. On average, they anticipate The Vitamin Shoppe's stock price to reach $4.95 in the next year. View Analyst Ratings for The Vitamin Shoppe.

Who are some of The Vitamin Shoppe's key competitors?

Some companies that are related to The Vitamin Shoppe include Sainsbury's (JSAIY), Ceconomy (MTTRY), GNC (GNC), DavidsTea (DTEA), Green Polkadot Box (GPDB) and Crumbs Bake Shop (CRMBQ).

Who are The Vitamin Shoppe's key executives?

The Vitamin Shoppe's management team includes the folowing people:

Mr. Colin Frederick Watts, Chief Exec. Officer and Director (Age 52)
Ms. Brenda M. Galgano CPA, Chief Financial Officer and Exec. VP (Age 49)
Mr. David M. Kastin, Sr. VP, Gen. Counsel & Corp. Sec. (Age 50)
Mr. Alexander W. Smith, Exec. Chairman (Age 65)
Mr. John Hnanicek, Chief Customer Innovation & Technology Officer and Sr. VP

Has The Vitamin Shoppe been receiving favorable news coverage?

Media headlines about VSI stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. The Vitamin Shoppe earned a news sentiment score of 0.16 on Accern's scale. They also gave headlines about the specialty retailer an impact score of 46.82 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are The Vitamin Shoppe's major shareholders?

The Vitamin Shoppe's stock is owned by a variety of of retail and institutional investors. Top institutional investors include SHAH CAPITAL MANAGEMENT (17.70%), VINTAGE CAPITAL MANAGEMENT LLC (17.70%), VINTAGE CAPITAL MANAGEMENT LLC (14.80%), BlackRock Inc. (12.50%), Dimensional Fund Advisors LP (6.92%) and Tamarack Advisers LP (4.63%). Company insiders that own The Vitamin Shoppe stock include B Michael Becker, Dan Lamadrid, Guillermo Marmol, John D Bowlin, Richard L Markee, Shah Capital Management and Vintage Capital Management Llc. View Institutional Ownership Trends for The Vitamin Shoppe.

Which institutional investors are selling The Vitamin Shoppe stock?

VSI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Landscape Capital Management L.L.C., OppenheimerFunds Inc., Guggenheim Capital LLC and Prudential Financial Inc.. View Insider Buying and Selling for The Vitamin Shoppe.

Which institutional investors are buying The Vitamin Shoppe stock?

VSI stock was bought by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Millennium Management LLC, Schwab Charles Investment Management Inc., Dimensional Fund Advisors LP, GSA Capital Partners LLP and California Public Employees Retirement System. Company insiders that have bought The Vitamin Shoppe stock in the last two years include Guillermo Marmol, John D Bowlin, Shah Capital Management and Vintage Capital Management Llc. View Insider Buying and Selling for The Vitamin Shoppe.

How do I buy shares of The Vitamin Shoppe?

Shares of VSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is The Vitamin Shoppe's stock price today?

One share of VSI stock can currently be purchased for approximately $5.25.

How big of a company is The Vitamin Shoppe?

The Vitamin Shoppe has a market capitalization of $122.37 million and generates $1.18 billion in revenue each year. The specialty retailer earns $-252,150,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. The Vitamin Shoppe employs 5,573 workers across the globe.

How can I contact The Vitamin Shoppe?

The Vitamin Shoppe's mailing address is 300 HARMON MEADOW BLVD., SECAUCUS NJ, 07094. The specialty retailer can be reached via phone at 201-868-5959 or via email at [email protected]

MarketBeat Community Rating for The Vitamin Shoppe (VSI)

Community Ranking:		1.9 out of 5 ()
Outperform Votes:		260 (Vote Outperform)
Underperform Votes:		416 (Vote Underperform)
Total Votes:		676

MarketBeat's community ratings are surveys of what our community members think about The Vitamin Shoppe and other stocks. Vote "Outperform" if you believe VSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSI will underperform the S&P 500 over the long term. You may vote once every thirty days.

The Vitamin Shoppe (NYSE:VSI) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

5 Wall Street analysts have issued ratings and price targets for The Vitamin Shoppe in the last 12 months. Their average twelve-month price target is $4.95, suggesting that the stock has a possible downside of 5.71%. The high price target for VSI is $7.00 and the low price target for VSI is $3.00. There are currently 2 sell ratings and 3 hold ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	1.60	1.67	1.67	1.67
Ratings Breakdown:	2 Sell Rating(s) 3 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 4 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 4 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 4 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$4.95	$4.95	$5.00	$5.00
Price Target Upside:	5.71% downside	32.00% upside	42.86% upside	42.86% upside

The Vitamin Shoppe (NYSE:VSI) Consensus Price Target History

Price Target History for The Vitamin Shoppe (NYSE:VSI)

The Vitamin Shoppe (NYSE:VSI) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
2/28/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$4.00 ➝ $3.75	Medium
11/9/2017	Barclays	Lower Price Target	Equal Weight	$6.00 ➝ $3.00	N/A
8/23/2017	Bank of America	Reiterated Rating	Underperform	$5.50 ➝ $5.00	Low
8/10/2017	Goldman Sachs Group	Reiterated Rating	Sell	$13.00 ➝ $6.00	Medium
8/10/2017	Deutsche Bank	Reiterated Rating	Hold	$14.00 ➝ $7.00	High
5/11/2017	Gabelli	Downgrade	Buy ➝ Hold		Medium
10/27/2016	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$33.00 ➝ $28.00	N/A
9/26/2016	Jefferies Group	Reiterated Rating	Hold	$28.00	N/A
8/3/2016	Wedbush	Reiterated Rating	Outperform	$39.00	N/A

(Data available from 5/26/2016 forward)

The Vitamin Shoppe (NYSE:VSI) Earnings History and Estimates Chart

Earnings by Quarter for The Vitamin Shoppe (NYSE:VSI)

The Vitamin Shoppe (NYSE:VSI) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.19 EPS
Next Year EPS Consensus Estimate: $-0.23 EPS

The Vitamin Shoppe (NYSE VSI) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/7/2018		$0.10					N/A
5/9/2018	Q1 2018	$0.10	$0.10	$293.44 million	$295.96 million	View	N/A
2/27/2018	Q4 2017	($0.20)	($0.17)	$269.24 million	$268.77 million	View	Listen
11/8/2017	Q3 2017	$0.17	($0.03)	$297.61 million	$288.20 million	View	N/A
8/9/2017	Q2 2017	$0.39	$0.23	$314.74 million	$304.84 million	View	Listen
5/10/2017	Q1 2017	$0.58	$0.37	$325.71 million	$316.90 million	View	N/A
3/1/2017	Q416	$0.40	$0.3580	$311.79 million	$304.87 million	View	Listen
11/2/2016	Q316	$0.50	$0.50	$317.18 million	$314.90 million	View	N/A
8/3/2016	Q216	$0.59	$0.55	$331.58 million	$332.70 million	View	N/A
5/4/2016	Q116	$0.65	$0.67	$339.76 million	$336.80 million	View	N/A
2/23/2016	Q415	$0.38	$0.39	$294.17 million	$293.50 million	View	Listen
11/4/2015	Q315	$0.47	$0.52	$317.28 million	$313.90 million	View	N/A
8/5/2015	Q215	$0.54	$0.57	$325.78 million	$322.30 million	View	N/A
5/6/2015	Q115	$0.74	$0.63	$344.66 million	$336.80 million	View	N/A
2/24/2015	Q414	$0.41	$0.41	$294.77 million	$290.10 million	View	N/A
11/4/2014	Q314	$0.52	$0.40	$314.60 million	$308.90 million	View	N/A
8/5/2014	Q214	$0.63	$0.62	$306.09 million	$306.20 million	View	N/A
5/7/2014	Q114	$0.68	$0.67	$302.82 million	$307.80 million	View	N/A
2/25/2014	Q413	$0.38	$0.37	$253.87 million	$256.40 million	View	N/A
11/5/2013	Q313	$0.52	$0.53	$273.87 million	$272.50 million	View	N/A
8/6/2013	Q2 2013	$0.60	$0.60	$284.28 million	$279.50 million	View	Listen
5/7/2013	Q1 2013	$0.69	$0.68	$282.71 million	$279.10 million	View	Listen
2/26/2013	Q4 2012	$0.40	$0.40	$223.88 million	$218.90 million	View	Listen
11/6/2012	Q312	$0.46	$0.54	$234.66 million	$239.00 million	View	N/A
8/7/2012		$0.51	$0.55			View	N/A
5/8/2012		$0.57	$0.61			View	N/A
2/28/2012		$0.32	$0.38			View	N/A
10/26/2011		$0.33	$0.41			View	N/A
7/28/2011		$0.38	$0.40			View	N/A
4/26/2011		$0.40	$0.47			View	N/A
2/16/2011		$0.21	$0.22			View	N/A
10/27/2010	Q3 2010	$0.24	$0.27			View	N/A
7/22/2010	Q2 2010	$0.26	$0.29			View	N/A
4/21/2010	Q1 2010	$0.27	$0.32			View	N/A
2/17/2010	Q4 2009	$0.09	$0.12			View	N/A
11/4/2009	Q3 2009		$0.09			View	N/A

(Earnings results data provided by Zacks Investment Research)

The Vitamin Shoppe (NYSE:VSI) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

The Vitamin Shoppe (NYSE VSI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.07%
Institutional Ownership Percentage: 88.47%

Insider Trading History for The Vitamin Shoppe (NYSE:VSI)

The Vitamin Shoppe (NYSE VSI) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2018	Shah Capital Management	Major Shareholder	Buy	156,142	$4.03	$629,252.26
2/5/2018	Shah Capital Management	Major Shareholder	Buy	300,000	$3.83	$1,149,000.00
2/1/2018	Shah Capital Management	Major Shareholder	Buy	5,800	$4.11	$23,838.00
1/5/2018	Vintage Capital Management Llc	Major Shareholder	Buy	326,692	$4.96	$1,620,392.32
1/2/2018	Vintage Capital Management Llc	Major Shareholder	Buy	133,804	$4.28	$572,681.12
12/29/2017	Vintage Capital Management Llc	Major Shareholder	Buy	234,343	$4.36	$1,021,735.48
8/25/2017	John D Bowlin	Director	Buy	40,000	$5.50	$220,000.00	56,028
3/8/2017	B. Michael Becker	Director	Sell	2,729	$19.41	$52,969.89	2,279
3/3/2017	Dan Lamadrid	CAO	Sell	5,432	$22.36	$121,459.52	16,817
3/3/2017	Richard L Markee	Director	Sell	100,000	$22.24	$2,224,000.00	160,990
11/8/2016	Dan Lamadrid	CAO	Sell	1,734	$23.20	$40,228.80
5/31/2016	Guillermo Marmol	Director	Buy	1,000	$30.23	$30,230.00	1,470
11/14/2014	Brenda Galgano	CFO	Sell	5,000	$48.77	$243,850.00
11/13/2014	Richard L Markee	Insider	Sell	27,774	$47.79	$1,327,319.46
9/18/2014	Anthony N Truesdale	CEO	Sell	61,792	$45.00	$2,780,640.00
9/18/2014	Richard L Markee	Insider	Sell	30,000	$45.00	$1,350,000.00
9/12/2014	Jean W Frydman	Insider	Sell	1,135	$43.40	$49,259.00
6/16/2014	Richard L Markee	Chairman	Sell	10,000	$45.00	$450,000.00
6/11/2014	Anthony Alfonso	Insider	Buy	5,000	$44.44	$222,200.00
5/1/2014	Anthony Truesdale	CEO	Sell	35,000	$47.18	$1,651,300.00	102,628
5/1/2014	Richard Markee	Chairman	Sell	10,000	$47.18	$471,800.00	60,419
4/1/2014	Anthony Truesdale	CEO	Sell	35,000	$47.91	$1,676,850.00	107,493
4/1/2014	Richard Markee	Insider	Sell	10,000	$47.91	$479,100.00	56,953
3/3/2014	Anthony Truesdale	CEO	Sell	35,000	$46.30	$1,620,500.00	107,447
3/3/2014	Richard Markee	Insider	Sell	10,000	$46.29	$462,900.00	56,470
1/10/2014	Anthony Truesdale	CEO	Sell	35,000	$48.51	$1,697,850.00	107,447
11/14/2013	Richard Markee	Chairman	Sell	50,000	$52.48	$2,624,000.00	62,291
11/13/2013	David Edwab	Director	Sell	3,738	$52.35	$195,684.30	3,224
2/28/2013	B. Michael Becker	Director	Buy	1,000	$51.95	$51,950.00

(Data available from 1/1/2013 forward)

The Vitamin Shoppe (NYSE VSI) News Headlines

Source:

Date	Headline
	Largest Sports Nutrition Launch in Vitamin Shoppe History www.prnewswire.com - May 21 at 4:14 PM
	Vitamin Shoppe (VSI) CFO Resigns www.streetinsider.com - May 19 at 9:41 AM
	Vitamin Shoppe CFO steps down seekingalpha.com - May 18 at 10:43 AM
	Vitamin Shoppe names Bill Wafford CFO finance.yahoo.com - May 18 at 10:43 AM
	Vitamin Shoppe Announces Chief Financial Officer Resignation finance.yahoo.com - May 18 at 10:43 AM
	The Vitamin Shoppe (VSI) Rating Lowered to Hold at ValuEngine www.americanbankingnews.com - May 16 at 4:51 PM
	PERFORMIX ioWHEY PROTEIN™ Debuts Only at The Vitamin Shoppe finance.yahoo.com - May 16 at 4:14 PM
	The Vitamin Shoppe (VSI) Upgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - May 16 at 1:35 PM
	Vitamin Shoppe Posts Weak Underlying Q1 2018 Results, Despite The Support From Shah And Vintage Capital seekingalpha.com - May 14 at 10:39 AM
	The Vitamin Shoppe (VSI) Given Consensus Recommendation of "Hold" by Brokerages www.americanbankingnews.com - May 13 at 3:36 PM
	Vitamin Shoppe's (VSI) CEO Colin Watts on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 13 at 10:12 AM
	The Vitamin Shoppe (VSI) Posts Earnings Results, Hits Estimates www.americanbankingnews.com - May 10 at 4:46 PM
	Edited Transcript of VSI earnings conference call or presentation 9-May-18 12:30pm GMT finance.yahoo.com - May 10 at 9:59 AM
	Vitamin Shoppe beats by $0.02, misses on revenue seekingalpha.com - May 9 at 9:47 AM
	More on Vitamin Shoppe's Q1 results seekingalpha.com - May 9 at 9:47 AM
	Vitamin Shoppe: 1Q Earnings Snapshot finance.yahoo.com - May 9 at 9:47 AM
	Vitamin Shoppe, Inc. Announces First Quarter 2018 Results finance.yahoo.com - May 9 at 9:47 AM
	What Analysts Recommend for Herbalife Stock finance.yahoo.com - May 8 at 9:38 AM
	The Vitamin Shoppe (VSI) to Release Earnings on Tuesday www.americanbankingnews.com - May 1 at 5:50 AM
	Contrasting Ceconomy (MTTRY) & The Vitamin Shoppe (VSI) www.americanbankingnews.com - April 30 at 11:23 AM
	The Vitamin Shoppe (VSI) & Ceconomy (MTTRY) Critical Review www.americanbankingnews.com - April 26 at 3:16 AM
	Vitamin Shoppe, Inc. Announces Fiscal First Quarter 2018 Earnings Release and Webcast Date www.prnewswire.com - April 25 at 2:34 PM
	Head-To-Head Survey: The Vitamin Shoppe (VSI) and Sainsbury's (JSAIY) www.americanbankingnews.com - April 24 at 7:56 AM
	Vitamin Shoppe works out board deal seekingalpha.com - April 23 at 4:13 PM
	Vitamin Shoppe to Appoint New Independent Directors to Board finance.yahoo.com - April 23 at 9:26 AM
	Insider Buying: The Vitamin Shoppe (VSI) Major Shareholder Acquires 156,142 Shares of Stock www.americanbankingnews.com - April 18 at 4:10 PM
	The Vitamin Shoppe (VSI) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - April 18 at 3:28 PM
	Analyzing Sainsbury's (JSAIY) & The Vitamin Shoppe (VSI) www.americanbankingnews.com - April 15 at 5:07 AM
	Vitamin Shoppe (VSI) Price Target Cut to $6.00 by Analysts at Barclays www.americanbankingnews.com - April 10 at 8:23 PM
	Vitamin Shoppe's (VSI) Hold Rating Reaffirmed at Deutsche Bank www.americanbankingnews.com - April 10 at 8:23 PM
	Analyzing Ceconomy (MTTRY) and Vitamin Shoppe (VSI) www.americanbankingnews.com - April 7 at 5:24 PM
	Ceconomy (MTTRY) & Vitamin Shoppe (VSI) Financial Contrast www.americanbankingnews.com - April 4 at 7:15 PM
	Vitamin Shoppe (VSI) Upgraded to "Buy" at ValuEngine www.americanbankingnews.com - April 2 at 10:52 PM
	Comparing J Sainsbury (JSAIY) and Vitamin Shoppe (VSI) www.americanbankingnews.com - April 1 at 3:20 PM
	Vitamin Shoppe (VSI) and The Competition Financial Contrast www.americanbankingnews.com - March 30 at 9:22 PM
	BRIEF-Vitamin Shoppe - Settled Repurchase Of $45.4 Million 2.25 Pct Convertible Senior Notes www.reuters.com - March 30 at 9:53 AM
	Vitamin Shoppe Inc (VSI) Receives Consensus Rating of "Hold" from Analysts www.americanbankingnews.com - March 24 at 3:36 PM
	Vitamin Shoppe Inc (VSI) Expected to Announce Quarterly Sales of $298.89 Million www.americanbankingnews.com - March 19 at 2:12 AM
	Zacks: Analysts Anticipate Vitamin Shoppe Inc (VSI) to Post $0.08 Earnings Per Share www.americanbankingnews.com - March 17 at 9:12 PM
	Bogle Investment Management L P DE Trims Holdings in Vitamin Shoppe Inc (VSI) www.americanbankingnews.com - March 6 at 5:08 AM
	Vitamin Shoppe Inc (VSI) Shares Bought by Landscape Capital Management L.L.C. www.americanbankingnews.com - March 4 at 2:29 PM
	Vitamin Shoppe (VSI) Downgraded by Zacks Investment Research www.americanbankingnews.com - March 2 at 2:02 PM
	FY2018 EPS Estimates for Vitamin Shoppe Inc (VSI) Decreased by Gabelli www.americanbankingnews.com - March 2 at 12:22 PM
	Vitamin Shoppe (VSI) Raised to "Buy" at ValuEngine www.americanbankingnews.com - March 2 at 12:06 AM
	Vitamin Shoppe Inc (VSI) to Post FY2022 Earnings of $0.80 Per Share, Gabelli Forecasts www.americanbankingnews.com - March 1 at 4:08 PM
	[$$] Vitamin Shoppe Looks to Hire Turnaround Firms: Sources finance.yahoo.com - March 1 at 9:26 AM
	Zacks: Analysts Anticipate Vitamin Shoppe Inc (VSI) to Announce $0.12 Earnings Per Share www.americanbankingnews.com - February 28 at 7:08 PM
	Vitamin Shoppe (VSI) Price Target Lowered to $3.75 at Morgan Stanley www.americanbankingnews.com - February 28 at 5:14 PM
	Vitamin Shoppe Inc (VSI) Receives Average Rating of "Hold" from Brokerages www.americanbankingnews.com - February 27 at 5:52 PM
	Vitamin Shoppe, Inc. Announces Fourth Quarter 2017 Results finance.yahoo.com - February 27 at 9:45 AM

The Vitamin Shoppe (NYSE:VSI) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

The Vitamin Shoppe (NYSE:VSI) Income Statement, Balance Sheet and Cash Flow Statement

The Vitamin Shoppe (NYSE VSI) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff